Innate Immunity: Molecular Mechanisms, Diseases & Therapeutics convenes leading researchers and clinicians to examine how innate immunity detects danger, shapes adaptive immunity, and drives disease and therapeutic response. A central focus of the meeting is how innate sensors distinguish self from non-self molecular patterns, informing both agonist and antagonist drug development across inflammatory, neurodegenerative, cardiometabolic, and autoimmune diseases. The program features joint plenary sessions, focused talks, and abstract-selected presentations highlighting advances in nucleic acid sensing pathways, including cGAS-STING. Mechanistic insights from biochemical and molecular studies are paired with discussions on translational challenges in drug discovery and clinical development. This meeting will be held jointly with T-Cells: From Basic Biology to Therapeutic Applications.
Topics: Immunology, Innate Immunity, Small Molecule Therapeutics, Therapeutic Innovation, Molecular Immunology, Drug Development, Adaptive Immunity